Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update
Source: SeekingAlpha
2026-01-22 18:06:16 ET
Shares of eyecare specialist Harrow, Inc. ( HROW ) have risen by 219% over the past three years as the company increased its focus on branded products segment and diversified away from its initial compounding business....
Read the full article on Seeking Alpha
For further details see:
Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update
Harrow Health Inc.
NASDAQ: HROW
HROW Trading
6.74% G/L:
$36.57 Last:
416,198 Volume:
$35.15 Open:
